Review began 03/30/2022 review ended 04/16/2022 published 04/19/2022 © copyright

HIGHLIGHTS

• who: Report et al. from the Laboratory parameters have published the research work: Review began 03/30/2022 Review ended 04/16/2022 Published 04/19/2022 u00a9 Copyright, in the Journal: (JOURNAL) of April/19,/2022
• what: Neuroendocrine prostate cancer can arise de novo or as the treatment-associated transformation of an established adenocarcinoma.

SUMMARY

Treatment-emergent transformed neuroendocrine prostate cancer (NEPC) is a highly aggressive type of prostate cancer that may arise from typical adenocarcinoma of the prostate, which is associated with rapidly progressive disease involving visceral sites and . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.